Archive · 9 Jun 2025
Advent to Invest $175M in Animal Drug Maker Felix
Advent, a company that invests in other businesses, is giving $175 million to Felix Pharmaceuticals.
Felix makes generic medicines for pets like dogs, cats, and horses.
The pet medicine market is growing.
Felix was created in 2015 and has 14 US FDA-approved products.
Advent hopes this investment will help Felix grow faster and become a global leader.
Felix supplies products to distributors and other generic pharmaceutical players.
The company aims to scale in the fast-evolving market of animal health.
Advent International will invest $175 million in Felix Pharmaceuticals.
Felix Pharmaceuticals, based in Dublin, Ireland, makes generic drugs for companion animals.
The investment aims to shape the companion animal health generics market.
Felix has 14 USFDA-approved products and 10 commercial products sold in the US.
The company was founded in 2015 by Shumeet Banerji, Jonathan Symonds, and Neeraj Agrawal.
- Who
- Advent International and Felix Pharmaceuticals.
- What
- Advent International will invest $175 million in Felix Pharmaceuticals.
- When
- The agreement was signed recently, announced on June 9.
- Where
- Dublin, Ireland, and manufacturing facilities in India.
- Why
- To capitalize on the growing animal health generics market and expand globally.
- Investor
- Advent International
- Investment Amount
- $175 million
- Company
- Felix Pharmaceuticals
- Industry
- Animal health generics
- Felix Products
- Off-patent medicines for companion animals
- USFDA approvals
- 14
- Clients served globally
- 200
